Hepatoma-derived growth factor (HDGF) is commonly over-expressed in human cancer cells. It was able to stimulate cell growth. The expression level of HDGF was reported to correlate with poor prognosis of cancer therapy. It was found that HDGF is over-expressed in the fractionated gamma radiation conditioned HepG2 cells, which have higher growth rate, lower radiosensitivity and higher drug sensitivity. The aim of the present study was to investigate the role of HDGF in mediating these changes in human cancer cells and the underlying mechanisms. The results indicate that transfection of HDGF cDNA carrying vector stimulated the growth of cancer cells while knock-down of HDGF by transfection of HDGF antisense oligos not only suppressed the growth but also triggered apoptosis in human cancer cells. It suggests that HDGF stimulates cancer cell growth and acts as a survival factor for human cancer cells. Mechanistic study showed that knock-down of HDGF may trigger apoptosis through the regulation of the apoptotic pathways. The apoptosis induced by HDGF knock-down was mediated by the BAD regulated intrinsic apoptotic pathway and the Fas regulated extrinsic apoptotic pathway. The HDGF knock-down induced apoptosis was also mediated by the changes in the activity of the cell survival pathways, including the Ras/Raf/MEK/ERK, PI3K/Akt, NFkappaB and Jak/STAT pathways. In addition to the growth promoting function, HDGF was found to regulate the radiosensitivity and chemosensitivity of cancer cells. Overexpression of HDGF reduced the radiosensitivity and the level of apoptosis induced by gamma radiation. On the contrast, overexpression of HDGF increased the chemosensitivity and the level of apoptosis induced by anti-cancer drugs, including Taxol, doxorubicin (Dox) and tamoxifen. The results indicated that HDGF may stimulate the growth, reduce the radiation sensitivity and increase the drug sensitivity of cancer cells. HDGF may also be responsible for the changes in cancer cell properties after fractionated gamma radiation treatment. The present findings suggest that HDGF may be a potential target for cancer therapy. / Tsang, Tsun Yee. / Adviser: Tim Tak Kwok. / Source: Dissertation Abstracts International, Volume: 70-06, Section: B, page: 3497. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references. / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts in English and Chinese. / School code: 1307.
| Identifer | oai:union.ndltd.org:cuhk.edu.hk/oai:cuhk-dr:cuhk_344281 |
| Date | January 2008 |
| Contributors | Tsang, Tsun Yee., Chinese University of Hong Kong Graduate School. Division of Biochemistry. |
| Source Sets | The Chinese University of Hong Kong |
| Language | English, Chinese |
| Detected Language | English |
| Type | Text, theses |
| Format | electronic resource, microform, microfiche, 1 online resource (xx, 207 leaves : ill.) |
| Rights | Use of this resource is governed by the terms and conditions of the Creative Commons “Attribution-NonCommercial-NoDerivatives 4.0 International” License (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
Page generated in 0.0031 seconds